Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) represents the most common arrhythmia leading to increased morbidity and mortality, yet, current treatment strategies have proven inadequate. Conventional treatment with antiarrhythmic drugs carries a high risk for proarrhythmias. The soluble epoxide hydrolase en...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Circ Arrhythm Electrophysiol
Egile Nagusiak: Sirish, Padmini, Li, Ning, Timofeyev, Valeriy, Zhang, Xiao-Dong, Wang, Lianguo, Yang, Jun, Lee, Kin Sing S., Bettaieb, Ahmed, Ma, Sin Mei, Lee, Jeong Han, Su, Demetria, Lau, Victor C., Myers, Richard E., Lieu, Deborah K., López, Javier E., Young, J. Nilas, Yamoah, Ebenezer N., Haj, Fawaz, Ripplinger, Crystal M., Hammock, Bruce D., Chiamvimonvat, Nipavan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869994/
https://ncbi.nlm.nih.gov/pubmed/27162031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.115.003721
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak